期刊文献+

2型糖尿病血糖控制水平与并发糖尿病肾病的风险研究 被引量:1

Relationship between control of blood glucose level and the risk of diabetic nephropathy in type 2 diabetic mellitus
下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)患者血糖控制水平与并发糖尿病肾病风险的关系。方法根据糖化血红蛋白(HbA1c)的含量将2型糖尿病患者分成血糖控制良好组(HbA1c≤7.0%,n=72)、血糖控制不佳组(HbA1c>7.0%,n=32),分别检测血清中胱抑素C(Cys C)、肌酐(Cr)、尿素(Urea)、超敏C反应蛋白(hs-CRP)和尿液中视黄醇结合蛋白(U-RBP)、尿微量清蛋白(U-mAlb)等项目。结果糖尿病各组血清Cys C、hs-CRP、U-RBP和U-mAlb与对照组比较均升高(P<0.05或P<0.01),并且患者血糖控制水平越差,Cys C、hs-CRP、U-RBP和UmAlb升高幅度越大。结论 T2DM患者HbA1c水平越高,血糖控制越差,并发糖尿病肾病的风险就越高。因此,控制好血糖对预防或延缓T2DM患者并发糖尿病肾病具有重要意义。 Objective To investigate the relationship between the control of blood glucose level and the risk of diabetic nephropathy (DN) in patients with type 2 diabetic mellitus (T2DM). Methods According to the level of glycosylated hemoglobin Alc (HbAlc), T2DM patients were assigned into 2 groups, including tight blood glucose control group (HbAlc7.0% ,n=72) and loose blood glucose control group (HbAlc)7.0% ,n=32). Serum levels of cystatin C (Cys C), creatine(Cr), urea,high sensitive C-reactive protein (hs-CRP) and urinary concentrations of retinol-binding protein (U-RBP), microalbumine (U-mAlb) were measured respectively. Results Serum levels of Cys C,hs-CRP,U-RBP and U-mAlb in all diabetic groups were significantly higher than control group (P(0.05), and worse blood glucose control could lead to higher level of serum Cys C,hs-CRP,U-RBP and U-mAlb(P〈0.05). Conclusion The higher levels of HbAlc in patients T2DM,the higher risk of DN. Efficient control of blood glucose level could be important to prevent and postpone the incidence of DN in patients with T2DM.
出处 《检验医学与临床》 CAS 2013年第19期2532-2533,共2页 Laboratory Medicine and Clinic
关键词 2型糖尿病 并发症 糖化血红蛋白 糖尿病肾病风险 type 2 diabetic mellitus complications glycosylated hemoglobin risk of diabetic nephropa-thy
  • 相关文献

参考文献7

  • 1Hahr AJ, Moliteh ME. Diabetes, cardiovascular risk and nephropathy[J]. Cardiol Clin, 2010,28(3) : 467-475.
  • 2Wada T, Furuichi K, Sakai N, et al. Up-regulation of mon- ocyte chemoattractant protein-1 in tubulointerstitial le- sions of human diabetic nephropathy [J]. Kidney Int, 2000,58(4) :1492-1499.
  • 3Dharnidharka VR, Kwon G, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney func- tion:a meta-analysis[J]. Am J Kidney Dis, 2002,40 (2) 221-227.
  • 4王玉洁,国霞,杨晶.视黄醇结合蛋白在糖尿病早期肾损害的监测[J].中国实验诊断学,2008,12(9):1128-1130. 被引量:10
  • 5Spanaus KS, Kollerits B, Ritz E, et al. Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kid- ney disease[J]. Clin Chem, 2010,56(5) : 740-749.
  • 6Yeo ES, Hwang JY,Park JE,et al. Tumor necrosis factor (TNF-alpha) and C-reactive protein(CRP) are positively associated with the risk of chronic kidney disease in pa- tients with type 2 diabetes [J]. Yonsei Med J, 2010, 51 (4):519 525.
  • 7周佳烨,吴炯,潘柏申.糖化血红蛋白测定在糖尿病诊断和治疗中的应用[J].检验医学,2010,25(8):583-587. 被引量:41

二级参考文献26

  • 1陈宇,钱荣立.糖尿病大鼠肾病早期肾小球基底膜改变与转铁蛋白尿的关系[J].中华医学杂志,1995,75(9):537-539. 被引量:15
  • 2Peterson KP,Pavlovich JG,Goldstein D,et al.What is hemoglobin A1c?An analysis of glycated hemoglobins by electrospray ionization mass spectrometry[J].Clin Chem,1998,44(9):1951-1958.
  • 3DCCT.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.The Diabetes Control and Complications Trial Research Group[J].N Engl J Med,1993,329(14):977-986.
  • 4UK.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).UK Prospective Diabetes Study (UKPDS) Group[J].Lancet,1998,352(9131):837-853.
  • 5EDPG.A desktop guide to type 2 diabetes mellitus.European Diabetes Policy Group 1999[J].Diabet Med,1999,16(9):716-730.
  • 6Hoelzel W,Miedema K.Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations[J].J Int Fed Clin Chem,1996,9(2):62-67.
  • 7Little RR,Rohlfing CL,Wiedmeyer HM,et al.The national glycohemoglobin standardization program:a five-year progress report[J].Clin Chem,2001,47(11):1985-1992.
  • 8Little RR,Wiedmeyer HM,England JD,et al.Interlaboratory standardization of measurements of glycohemoglobins[J].Clin Chem,1992,38(12):2472-2478.
  • 9Goldstein DE,Little RR,Lorenz RA,et al.Tests of glycemia in diabetes[J].Diabetes Care,2004,27(7):1761-1773.
  • 10Report of the ADA/EASD/IDF Working Group of the HbA1c Assay,London,UK,January 2004[J].Diabetologia,2004,47:R53-R54.

共引文献49

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部